Excited to announce 2 of my abstracts have been accepted for poster presentation at #ATS2025 Thankful to my mentors Joseph Sassine and Taha A, MD for all the support American Thoracic Society (ATS) OU DOM Resident Research OU College of Medicine OU Internal Medicine Residency OU Health Stephenson Cancer Center University of Oklahoma Research OU Health

BMT pharmacy specialist at OU Health Medical Center. Daily rounding, medication management, patient counseling, collaborative treatment plans, cross coverage of inpatient oncology services, and maintenance of policies/protocols related to BMT and oncology services.

Work with great docs like Joseph Sassine and Taha A, MD. oumedicine.wd5.myworkdayjobs.com/en-US/OUHealth… #TwitterRX

Excited to share that 2 of our abstracts have been accepted for poster presentation at Fred Hutch Cancer Center Cancer Center ID in Immunocompromised Host Symposium. Grateful to have supporting mentors like Taha A, MD and Joseph Sassine OU DOM Resident Research OU Internal Medicine Residency OU College of Medicine

The PGY2 ID OU College of Pharmacy Residency Programs is going into phase 2. Id be happy to have a chat with candidates on Thursday or Friday. #TwitteRx

Our new paper on vancomycin AUC dosing in obesity is out. Rates of AKI were lower in the AUC group compared to the trough group (11.3% versus 25.2%, p<0.001). This work was led by Corey Guidry, PharmD, BCPS . Emily Siegrist was on it as well. Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟

Had a great time in Syracuse presenting Medicine Grand Rounds earlier today on Infections after CAR T at SUNY Upstate and meeting some great ID colleagues there!

Spoke to the Oklahoma Thoracic Society on pulmonary NTM infections, the evolving epidemiology, the diagnostic and therapeutic challenges, and emerging management strategies. Thanks Tony Abdo for the invitation!

Invasive fusariosis after CAR T is rare but can be consequential. Here’s our case of cutaneous fusariosis after CD19 CAR T, with Rita Wilson Dib Emily Siegrist J Holter Chakrabarty Jose Andres Henao Cordero MD and others, out in ASM Case Reports! OU College of Medicine journals.asm.org/doi/10.1128/as…

Very proud of my mentee Bibi Maryam who is presenting TWO posters at the 5th symposium on ID in IC hosts Fred Hutch Cancer Center, on PCP incidence after CAR T and on infection-related mortality after CAR T! Taha A, MD OU DOM Resident Research OU College of Medicine OU Health OU Internal Medicine Residency

Presented our research at Fred Hutch Cancer Center 5th ID in immunocompromised host symposium. Grateful to my mentors Joseph Sassine and Taha A, MD Noha N. Soror, MD, MSc. 𓂀 for their support . #CART #BMT #PJP OU DOM Resident Research OU College of Medicine OU Health Stephenson Cancer Center OU Internal Medicine Residency

⭐️ trainee and mentor. We’re proud of our multidisciplinary collaborations as we advance our #CARtcell program forward, infections control and management are at the core of that OU Health OU Health Stephenson Cancer Center OU College of Medicine #bmtsm #Cell_Therapy #lymsm

And part 2 is out now: How to prevent travel-related infections in the transplant recipient, check it out! Emily Siegrist Rita Wilson Dib Jose Andres Henao Cordero MD Therapeutic Advances in Infectious Disease Andrés Henao, MD, PhD journals.sagepub.com/doi/full/10.11…

Out now in JAC-AMR, our real world analysis of BCID fungal panel for diagnosis of fungemia, led by the great Emily Siegrist - Sensitivity of 94%, lower than anticipated Bryan White Rita Wilson Dib OU College of Medicine OU Health academic.oup.com/jacamr/article…

🚨New article alert! We used the GenMark panel for rapid yeast ID in blood cultures. We got faster ID, but didn’t de-escalate therapy based on it. Full story + data here 👉 academic.oup.com/jacamr/article… Rita Wilson Dib Joseph Sassine SIDP

ID fellowship applicants, make sure to check out our program OU College of Medicine: 2 year clinical program - 3 tracks (TxID, hosp epi, trop med) - Path for crit care fellowship - 12 credit certificates in year 2 medicine.ouhsc.edu/academic-depar…

There is limited data on the need for monitoring with daptomycin in OPAT. Our OPAT team lead by Meaghan Wiley examined this question in 127 OPAT patients. They were on daptomycin (median 7.4 mg/kg) for a median of 37 days. 11.8% experienced CK elevation with a median of 13 days

(IQR 9-16) providing some support for the IDSA guideline recommendation for weekly lab monitoring on daptomycin OPAT. doi.org/10.1017/ash.20… Joseph Sassine OU College of Pharmacy Residency Programs Emily Siegrist

Tick bites on the rise in Oklahoma and across the country kfor.com/news/local/tic…